Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome (DS): 3-Year Interim Results of an Open-Label Extension (OLE) Trial (GWPCARE5)

被引：0
|
作者：
Halford, Jonathan J. [1 ]
Scheffer, Ingrid [2 ,3 ]
Nabbout, Rima [4 ]
Sanchez-Carpintero, Rocio [5 ]
Malawky, Yael Shiloh [6 ]
Wong, Matthew [7 ]
Checketts, Daniel [8 ]
Dunayevich, Eduardo [9 ]
机构：
[1] Med Univ South Carolina, Dept Neurol, Translat Res Unit, Charleston, SC 29425 USA
[2] Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia
[3] Royal Childrens Hosp, Melbourne, Vic, Australia
[4] Necker Enfants Malades Hosp, Paris, France
[5] Clin Univ Navarra, Pamplona, Spain
[6] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[7] Wake Forest Baptist Med Ctr, Winston Salem, NC USA
[8] GW Res Ltd, Carlsbad, CA USA
[9] Greenwich Biosci Inc, Carlsbad, CA USA
来源：
NEUROLOGY | 2020年 / 94卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
439
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Long- term Safety and Efficacy of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC): 3-Year Results From GWPCARE6 Open-Label Extension (OLE)
    Thiele, E.
    Bebin, E.
    Filloux, F.
    Jansen, F.
    Kwan, P.
    Loftus, R.
    Sahebkar, F.
    Sparagana, S.
    Lawson, J.
    Wheless, J.
    ANNALS OF NEUROLOGY, 2023, 94 : S53 - S53
  • [22] Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Treatment of Seizures Associated with Tuberous Sclerosis Complex (TSC) in an Open-Label Extension (OLE) Trial (GWPCARE6)
    Wheless, J.
    Bebin, E.
    Filloux, F.
    Kwan, P.
    Jansen, F.
    Loftus, R.
    Sahebkar, F.
    Sparagana, S.
    Thiele, E.
    ANNALS OF NEUROLOGY, 2021, 90 : S129 - S130
  • [23] Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Treatment of Seizures Associated with Tuberous Sclerosis Complex (TSC) in an Open-Label Extension (OLE) Trial (GWPCARE6)
    Wheless, James
    Bebin, E. Martina
    Filloux, Francis
    Kwan, Patrick
    Jansen, Floor E.
    Loftus, Rachael
    Sahebkar, Farhad
    Sparagana, Steven
    Thiele, Elizabeth
    NEUROLOGY, 2021, 96 (15)
  • [24] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [25] Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
    Patel, Anup D.
    Mazurkiewicz-Beldzinska, Maria
    Chin, Richard F.
    Gil-Nagel, Antonio
    Gunning, Boudewijn
    Halford, Jonathan J.
    Mitchell, Wendy
    Scott Perry, Michael
    Thiele, Elizabeth A.
    Weinstock, Arie
    Dunayevich, Eduardo
    Checketts, Daniel
    Devinsky, Orrin
    EPILEPSIA, 2021, 62 (09) : 2228 - 2239
  • [26] Long-term safety and efficacy of add-on cannabidiol for tuberous sclerosis complex-associated seizures: 3-year results from an open-label extension trial
    Sahebkar, F.
    Thiele, E. A.
    Bebin, E. M.
    Filloux, F.
    Jansen, F. E.
    Kwan, P.
    Loftus, R.
    Sparagana, S.
    Lawson, J.
    Wheless, J.
    EPILEPSIA, 2023, 64 : 289 - 290
  • [27] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients With Crohn's Disease: 3-Year Interim Results From the Ongoing Phase 2 Open-Label Extension Study
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, Weijiang
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S466 - S466
  • [28] Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
    Santos, Raul D.
    Duell, P. Barton
    East, Cara
    Guyton, John R.
    Moriarty, Patrick M.
    Chin, Wai
    Mittleman, Robert S.
    EUROPEAN HEART JOURNAL, 2015, 36 (09) : 566 - 575
  • [29] Long-term safety and efficacy of rotigotine in idiopathic RLS: 3-year results from a multinational, open-label trial
    Garcia-Borreguero, D.
    JOURNAL OF SLEEP RESEARCH, 2008, 17 : 113 - 113
  • [30] Long-term safety and efficacy of rotigotine in idiopathic RLS: 3-year results from a multinational open-label trial
    Garcia-Borreguero, D.
    Poewe, W.
    Hoegl, B.
    Kohnen, R.
    Stiasny-Kolster, K.
    Keffel, J.
    Schollmayer, E.
    Boroojerdi, B.
    Trenktwalder, C.
    Oertel, W.
    MOVEMENT DISORDERS, 2008, 23 (01) : S367 - S367
12345